Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients
Not yet recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Device: Capnography
- Registration Number
- NCT06108973
- Lead Sponsor
- Employee's State Insurance Corporation, New Delhi
- Brief Summary
All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .
- Detailed Description
Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
- Both Sex All Age Group Patient willing to give consent COPD patient
Exclusion Criteria
- Not willing to give consent Cancerous Lung Lung Lobectomy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Normal Patients Capnography Normal patients without any Lung Pathology for General Anesthesia COPD patients Capnography Established Chronic Obstructive Pulmonary Disease for General Anesthesia
- Primary Outcome Measures
Name Time Method Estimation of Volume consumption of Sevoflurane 8 weeks The consumption is expressed in Volume ml/kg
- Secondary Outcome Measures
Name Time Method